The Collaborations among Healthcare Systems, Research Institutions, and Industry on Artificial Intelligence Research and Development

TL;DR

This study analyzes collaborative networks among healthcare, research, and industry in China's AI healthcare efforts, highlighting enthusiasm, barriers, and future priorities for AI development.

Contribution

It provides a comprehensive characterization of AI collaboration networks, identifies key challenges, and offers strategic recommendations for advancing AI in healthcare.

Findings

High clinician interest in AI but limited engagement in development

Data privacy concerns hinder data sharing and collaboration

Future focus on lesion screening, diagnosis, and workflow enhancement

Abstract

Objectives: The integration of Artificial Intelligence (AI) in healthcare promises to revolutionize patient care, diagnostics, and treatment protocols. Collaborative efforts among healthcare systems, research institutions, and industry are pivotal to leveraging AI's full potential. This study aims to characterize collaborative networks and stakeholders in AI healthcare initiatives, identify challenges and opportunities within these collaborations, and elucidate priorities for future AI research and development. Methods: This study utilized data from the Chinese Society of Radiology and the Chinese Medical Imaging AI Innovation Alliance. A national cross-sectional survey was conducted in China (N = 5,142) across 31 provincial administrative regions, involving participants from three key groups: clinicians, institution professionals, and industry representatives. The survey explored diverse aspects including current AI usage in healthcare, collaboration dynamics, challenges encountered, and research and development priorities. Results: Findings reveal high interest in AI among clinicians, with a significant gap between interest and actual engagement in development activities. Despite the willingness to share data, progress is hindered by concerns about data privacy and security, and lack of clear industry standards and legal guidelines. Future development interests focus on lesion screening, disease diagnosis, and enhancing clinical workflows. Conclusion: This study highlights an enthusiastic yet cautious approach toward AI in healthcare, characterized by significant barriers that impede effective collaboration and implementation. Recommendations emphasize the need for AI-specific education and training, secure data-sharing frameworks, establishment of clear industry standards, and formation of dedicated AI research departments.